Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Language
Publication year range
1.
PLoS Pathog ; 19(3): e1011260, 2023 03.
Article in English | MEDLINE | ID: mdl-36972292

ABSTRACT

Leprosy, caused by Mycobacterium leprae, rarely affects children younger than 5 years. Here, we studied a multiplex leprosy family that included monozygotic twins aged 22 months suffering from paucibacillary leprosy. Whole genome sequencing identified three amino acid mutations previously associated with Crohn's disease and Parkinson's disease as candidate variants for early onset leprosy: LRRK2 N551K, R1398H and NOD2 R702W. In genome-edited macrophages, we demonstrated that cells expressing the LRRK2 mutations displayed reduced apoptosis activity following mycobacterial challenge independently of NOD2. However, employing co-immunoprecipitation and confocal microscopy we showed that LRRK2 and NOD2 proteins interacted in RAW cells and monocyte-derived macrophages, and that this interaction was substantially reduced for the NOD2 R702W mutation. Moreover, we observed a joint effect of LRRK2 and NOD2 variants on Bacillus Calmette-Guérin (BCG)-induced respiratory burst, NF-κB activation and cytokine/chemokine secretion with a strong impact for the genotypes found in the twins consistent with a role of the identified mutations in the development of early onset leprosy.


Subject(s)
Genetic Predisposition to Disease , Leprosy , Child , Humans , Alleles , Genotype , Leprosy/genetics , Mutation , Nod2 Signaling Adaptor Protein/genetics , Leucine-Rich Repeat Serine-Threonine Protein Kinase-2/genetics
2.
Cells ; 10(9)2021 08 27.
Article in English | MEDLINE | ID: mdl-34571865

ABSTRACT

Leprosy reactional episodes are acute inflammatory events that may occur during the clinical course of the disease. Type 1 reaction (T1R) is associated with an increase in neural damage, and the understanding of the molecular pathways related to T1R onset is pivotal for the development of strategies that may effectively control the reaction. Interferon-gamma (IFN-γ) is a key cytokine associated with T1R onset and is also associated with autophagy induction. Here, we evaluated the modulation of the autophagy pathway in Mycobacterium leprae-stimulated cells in the presence or absence of IFN-γ. We observed that IFN-γ treatment promoted autophagy activation and increased the expression of genes related to the formation of phagosomes, autophagy regulation and function, or lysosomal pathways in M. leprae-stimulated cells. IFN-γ increased interleukin (IL)-15 secretion in M. leprae-stimulated THP-1 cells in a process associated with autophagy activation. We also observed higher IL15 gene expression in multibacillary (MB) patients who later developed T1R during clinical follow-up when compared to MB patients who did not develop the episode. By overlapping gene expression patterns, we observed 13 common elements shared between T1R skin lesion cells and THP-1 cells stimulated with both M. leprae and IFN-γ. Among these genes, the autophagy regulator Translocated Promoter Region, Nuclear Basket Protein (TPR) was significantly increased in T1R cells when compared with non-reactional MB cells. Overall, our results indicate that IFN-γ may induce a TPR-mediated autophagy transcriptional program in M. leprae-stimulated cells similar to that observed in skin cells during T1R by a pathway that involves IL-15 production, suggesting the involvement of this cytokine in the pathogenesis of T1R.


Subject(s)
Autophagy/genetics , Interleukin-15/genetics , Leprosy/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Cells, Cultured , Child , Cytokines/genetics , Female , Gene Expression/genetics , Humans , Interferon-gamma/genetics , Leprosy/microbiology , Male , Middle Aged , Mycobacterium leprae/pathogenicity , Skin/metabolism , Skin/microbiology , THP-1 Cells/metabolism , Young Adult
3.
Front Immunol ; 11: 1493, 2020.
Article in English | MEDLINE | ID: mdl-32849508

ABSTRACT

In HIV-infected individuals, a paradoxical clinical deterioration may occur in preexisting leprosy when highly active antiretroviral therapy (HAART)-associated reversal reaction (RR) develops. Leprosy-HIV co-infected patients during HAART may present a more severe form of the disease (RR/HIV), but the immune mechanisms related to the pathogenesis of leprosy-HIV co-infection remain unknown. Although the adaptive immune responses have been extensively studied in leprosy-HIV co-infected individuals, recent studies have described that innate immune cells may drive the overall immune responses to mycobacterial antigens. Monocytes are critical to the innate immune system and play an important role in several inflammatory conditions associated with chronic infections. In leprosy, different tissue macrophage phenotypes have been associated with the different clinical forms of the disease, but it is not clear how HIV infection modulates the phenotype of innate immune cells (monocytes or macrophages) during leprosy. In the present study, we investigated the phenotype of monocytes and macrophages in leprosy-HIV co-infected individuals, with or without RR. We did not observe differences between the monocyte profiles in the studied groups; however, analysis of gene expression within the skin lesion cells revealed that the RR/HIV group presents a higher expression of macrophage scavenger receptor 1 (MRS1), CD209 molecule (CD209), vascular endothelial growth factor (VEGF), arginase 2 (ARG2), and peroxisome proliferator-activated receptor gamma (PPARG) when compared with the RR group. Our data suggest that different phenotypes of tissue macrophages found in the skin from RR and RR/HIV patients could differentially contribute to the progression of leprosy.


Subject(s)
Antiretroviral Therapy, Highly Active/adverse effects , HIV Infections/immunology , HIV-1/physiology , Leprosy/immunology , Macrophages/immunology , Monocytes/immunology , Mycobacterium leprae/physiology , Adult , Aged , Cell Differentiation , Coinfection , Disease Progression , Female , HIV Infections/complications , HIV Infections/therapy , Humans , Leprosy/complications , Leprosy/therapy , Male , Middle Aged , Scavenger Receptors, Class A/metabolism
4.
Immunohorizons ; 4(2): 47-56, 2020 02 07.
Article in English | MEDLINE | ID: mdl-32034084

ABSTRACT

Erythema nodosum leprosum (ENL) is an inflammatory complication in leprosy. Yet, the involvement of ENL neutrophils in the inflammatory response against Mycobacterium leprae remains poorly explored. Our primary aim was to investigate the utility of the surface expression of neutrophil IL-10R1 as an ENL biomarker and, secondarily, to evaluate whether leprosy or healthy M. leprae-stimulated neutrophils produce cytokines and are able to respond to IL-10. We, in this study, describe a subpopulation of circulating neutrophils of ENL patients that exclusively expressed IL-10R1, providing evidence that IL-10R1+ neutrophils are present in ENL lesions. It was also found that ENL neutrophils, but not those of nonreactional leprosy controls, were able to secret detectable levels of TNF ex vivo and the addition of IL-10 blocked TNF release. It was likewise observed that M. leprae-stimulated, healthy neutrophils expressed IL-10R1 in vitro, and ENL-linked cytokines were released by M. leprae-cultured neutrophils in vitro. Moreover, consistent with the presence of a fully functional IL-10R, the addition of IL-10 prevented the release of M. leprae-induced cytokines. Most importantly, dead M. leprae revealed its superior capacity to induce CCL4 and IL-8 in primary neutrophils over live Mycobacterium, suggesting that M. leprae may hamper the inflammatory machinery as an immune escape mechanism.


Subject(s)
Erythema Nodosum/immunology , Interleukin-10 Receptor alpha Subunit/metabolism , Interleukin-10/pharmacology , Leprosy, Lepromatous/immunology , Neutrophils/metabolism , Skin/immunology , Adult , Cells, Cultured , Cytokines/metabolism , Erythema Nodosum/drug therapy , Female , Humans , Inflammation Mediators/metabolism , Leprosy, Lepromatous/drug therapy , Male , Middle Aged , Mycobacterium leprae/immunology , Neutrophil Infiltration/drug effects , Neutrophils/drug effects , Neutrophils/microbiology , Thalidomide/therapeutic use , Young Adult
5.
J Infect Dis ; 216(12): 1635-1643, 2017 12 19.
Article in English | MEDLINE | ID: mdl-29272525

ABSTRACT

Background: Leprosy, the leading infectious cause of disability worldwide, remains a major public health challenge in the most severely affected countries despite the sharp decline in new cases in recent years. The search for biomarkers is essential to achieve a better understanding of the molecular and cellular mechanisms underlying the disease. Methods: Pentraxin-3 (PTX3) analyses of sera from 87 leprosy patients with or without reactions were conducted via enzyme-linked immunosorbent assay. In situ identification of PTX3 in skin lesion was confirmed by quantitative reverse-transcription polymerase chain reaction, immunohistochemistry, and immunofluorescence assays. Results: We found that PTX3 serum levels were higher in multibacillary patients when evaluated before the onset of acute erythema nodosum leprosum (ENL) and persistently elevated during reaction. Thalidomide treatment reduced PTX3 in the serum 7 days after starting treatment. In situ analyses have also demonstrated enhancement of PTX3 in ENL lesions and showed that treatment with thalidomide reduced its expression and the prominent neutrophilic infiltrate, a hallmark of the disease. Conclusions: In summary, our study provides in vivo evidence that PTX3 is enhanced during ENL but not in reversal reaction and provides a new molecular target in ENL pathogenesis.


Subject(s)
Biomarkers/analysis , C-Reactive Protein/analysis , Erythema Nodosum/diagnosis , Erythema Nodosum/pathology , Leprosy, Lepromatous/diagnosis , Leprosy, Lepromatous/pathology , Serum Amyloid P-Component/analysis , Adolescent , Adult , Aged , C-Reactive Protein/genetics , Case-Control Studies , Child , Enzyme-Linked Immunosorbent Assay , Female , Fluorescent Antibody Technique , Humans , Immunohistochemistry , Leprostatic Agents/administration & dosage , Male , Middle Aged , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Serum Amyloid P-Component/genetics , Skin/pathology , Thalidomide/administration & dosage , Young Adult
6.
s.l; Elsevier; 2017. 10 p. tab, graf.
Non-conventional in English | HANSEN, Sec. Est. Saúde SP, Hanseníase Leprosy, SESSP-ILSLPROD, Sec. Est. Saúde SP, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1052567

ABSTRACT

Our previous study has demonstrated that IL-10 may modulate both indoleamine 2,3-dioxygenase (IDO) and CD163 expression in lepromatous leprosy (LL) cells, favoring Mycobacterium leprae persistence through induction of regulatory pathways and iron storage. Here, we observed that in LL lesion cells there is an increase in the expression of proteins involved in iron metabolism such as hemoglobin (Hb), haptoglobin, heme oxygenase 1 and transferrin receptor 1 (TfR1) when compared to tuberculoid leprosy (BT) cells. We also found increased iron deposits and diminished expression of the iron exporter ferroportin 1 in LL lesion cells. Hemin, but not FeSO stimulation, was able to enhance M. leprae viability by a mechanism that involves IDO. Analysis of cell phenotype in lesions demonstrated a predominance of M2 markers in LL when compared with BT lesion cells. A positive correlation between CD163 and PPARG with the bacillary index (BI) was observed. In contrast, TNF, STAT1 and CSF2 presented a negative correlation with the BI. In summary, this study demonstrates that iron may regulate IDO expression by a mechanism that involves IL-10, which may contribute for the predominance of M2-like phenotype in LL lesions that favors the phagocytosis and maintenance of M. leprae in host cells.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Immunoblotting , Leprosy, Lepromatous/metabolism , Leprosy, Lepromatous/microbiology , Immunoenzyme Techniques , Reverse Transcriptase Polymerase Chain Reaction , Indoleamine-Pyrrole 2,3,-Dioxygenase/physiology , Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism , Iron/physiology , Iron/metabolism , Mycobacterium leprae/physiology , Mycobacterium leprae/metabolism
7.
PLoS Negl Trop Dis ; 10(8): e0004955, 2016 08.
Article in English | MEDLINE | ID: mdl-27556927

ABSTRACT

Erythema Nodosum Leprosum (ENL) is an immune reaction in leprosy that aggravates the patient´s clinical condition. ENL presents systemic symptoms of an acute infectious syndrome with high leukocytosis and intense malaise clinically similar to sepsis. The treatment of ENL patients requires immunosuppression and thus needs to be early and efficient to prevent both disabilities and permanent nerve damage. Some patients experience multiple episodes of ENL and prolonged use of immunosuppressive drugs may lead to serious adverse effects. Thalidomide treatment is extremely effective at ameliorating ENL symptoms. Several mechanisms have been proposed to explain the efficacy of thalidomide in ENL, including the inhibition of TNF production. Given its teratogenicity, thalidomide is prohibitive for women of childbearing age. A rational search for molecular targets during ENL episodes is essential to better understand the disease mechanisms involved, which may also lead to the discovery of new drugs and diagnostic tests. Previous studies have demonstrated that IFN-γ and GM-CSF, involved in the induction of CD64 expression, increase during ENL. The aim of the present study was to investigate CD64 expression during ENL and whether thalidomide treatment modulated its expression. Leprosy patients were allocated to one of five groups: (1) Lepromatous leprosy, (2) Borderline leprosy, (3) Reversal reaction, (4) ENL, and (5) ENL 7 days after thalidomide treatment. The present study demonstrated that CD64 mRNA and protein were expressed in ENL lesions and that thalidomide treatment reduced CD64 expression and neutrophil infiltrates-a hallmark of ENL. We also showed that ENL blood neutrophils exclusively expressed CD64 on the cell surface and that thalidomide diminished overall expression. Patient classification based on clinical symptoms found that severe ENL presented high levels of neutrophil CD64. Collectively, these data revealed that ENL neutrophils express CD64, presumably contributing to the immunopathogenesis of the disease.


Subject(s)
Erythema Nodosum/immunology , Leprostatic Agents/therapeutic use , Neutrophils/drug effects , Neutrophils/immunology , Receptors, IgG/genetics , Thalidomide/therapeutic use , Adolescent , Adult , Aged , Biopsy , Erythema Nodosum/diagnosis , Erythema Nodosum/drug therapy , Erythema Nodosum/microbiology , Female , Humans , Leprosy, Borderline/drug therapy , Leprosy, Borderline/immunology , Leprosy, Borderline/microbiology , Leprosy, Lepromatous/drug therapy , Leprosy, Lepromatous/immunology , Leprosy, Lepromatous/microbiology , Male , Middle Aged , Receptors, IgG/immunology , Skin/microbiology , Skin/pathology , Young Adult
8.
J Neuropathol Exp Neurol ; 75(3): 272-83, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26888306

ABSTRACT

Mycobacterium leprae (ML) infection causes nerve damage that often leads to permanent loss of cutaneous sensitivity and limb deformities, but understanding of the pathogenesis of leprous neuropathy that would lead to more effective treatments is incomplete. We studied reactional leprosy patients with (n = 9) and without (n = 8) acute neuritis. Nerve conduction studies over the course of the reactional episode showed the findings of demyelination in all patients with neuritis. Evaluation of patient sera revealed no correlation of the presence of antibodies against gangliosides and the clinical demyelination. In nerve biopsies of 3 patients with neuritis, we identified tumor necrosis factor (TNF), TNF receptors, and TNF-converting enzyme in Schwann cells (SCs) using immunofluorescence. To elucidate immunopathogenetic mechanisms, we performed experiments using a human SC line. ML induced transmembrane TNF and TNF receptor 1 expression in the SCs; TNF also induced interleukin (IL)- 6 and IL-8 production by the SCs; and ML induced IL-23 secretion, indicating involvement of this previously unrecognized factor in leprosy nerve damage. These data suggest that ML may contribute to TNF-mediated inflammation and focal demyelination by rendering SCs more sensitive to TNF within the nerves of patients with leprous neuropathy.


Subject(s)
Cytokines/metabolism , Demyelinating Diseases/complications , Demyelinating Diseases/metabolism , Leprosy/complications , Neuritis/complications , Adult , Aged , Cell Line, Transformed , Cytokines/genetics , Demyelinating Diseases/pathology , Electric Stimulation , Female , Gene Expression/drug effects , Gene Expression/physiology , Humans , Male , Middle Aged , Mycobacterium leprae/physiology , Nerve Tissue Proteins/metabolism , Neural Conduction/physiology , Neurologic Examination , Reaction Time , Schwann Cells/drug effects , Schwann Cells/metabolism , Tumor Necrosis Factor-alpha/pharmacology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...